Investigates teriflunomide's effects on clinical outcomes in HAM/TSP, suggesting potential benefits.
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic inflammatory disease of the central nervous system (CNS).
No takes yet. Share an insight, caveat, or question.
NAHAYATI et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: